Results 11 to 20 of about 226,969 (309)

Effectiveness and adverse effects of astrazeneca and pfizer COVID-19 vaccines among medical students in Oman: A comparative study

Biomedical and Biotechnology Research Journal, 2023
Background: Immunization against severe acute respiratory syndrome coronavirus 2 became necessary to control the menace of COVID-19. However, the safety of COVID-19 vaccines must be monitored continuously.
Mohan Bilikallahalli Sannathimmappa, Vinod Nambiar, Rajeev Aravindakshan, Muqeet Fauzan Baig, Ahmed Kifah Hassan, Maryam Saud Mohammed Al-Balushi   +5 more
doaj   +1 more source

Superficial Thrombophlebitis of the Penis following AstraZeneca ChAdOx1-S Vaccination: A Rare Venous Thromboembolic Complication

European Journal of Case Reports in Internal Medicine, 2022
Penile Mondor’s disease is a rare condition characterised by superficial thrombophlebitis of the penis which is usually self-limiting. The cause is often unknown. The AstraZeneca ChAdOx1-S vaccine has been found to cause a hypercoagulable state, which is
Joshua Winston, Kale Munien
doaj   +1 more source

Evidenzbasierte Entscheidungen statt Tunnelblick

Monitor Versorgungsforschung, 2021
Berichte über seltene schwere Komplikationen im Zusammenhang mit der Verwendung des „Vaxzevria“-Impfstoffes von AstraZeneca haben zu einer erheblichen Verunsicherung der Impflinge geführt.
Dr. Josef Leiter, Peter Stegmaier
doaj   +1 more source

Bace1-dependent amyloid processing regulates hypothalamic leptin sensitivity in obese mice [PDF]

, 2018
We thank AstraZeneca for providing AZ-4217, Mark Smith (Imperial College, London) and Yuchio Yanagawa (Gunma University, Maebashi) for VGlut2-GFP and GAD67-GFP tissue, respectively.
Allsop, David J. P., Ashford, Michael L. J., Bailey, Charlotte L. S., Cavellini, Daniella L., Dale, J. Kim, Heisler, Lora K., Irvine, Stuart W., Jalicy, Susan M., Liddell, Mary K., Liu, Yu-Ru, McCrimmon, Rory J., McGinley, Christopher, McNeilly, Alison D., Meakin, Paul J., Montagut, Gemma, Parmionova, Karolina   +15 more
core   +5 more sources

Post COVID-19 vaccination Guillain-Barre syndrome: three cases

Human Vaccines & Immunotherapeutics, 2022
Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy. In two-thirds of patients, it is preceded by an upper respiratory or gastrointestinal tract infection.
Seyedehnarges Tabatabaee, Fatemeh Rezania, Sayed Mohammed Jawad Alwedaie, Ensieh Malekdar, Zahra Badi, Seyed Mohammad Tabatabaei, Zahra Mirzaasgari   +6 more
doaj   +1 more source

STUDI KOMPARATIF METODE IJTIHAD MAJELIS ULAMA INDONESIA DAN BAHTSUL MASAIL NAHDLATUL ULAMA TENTANG FATWA VAKSIN ASTRAZENECA

Asy-Syari'ah, 2022
: This paper aims to compare the ijtihad methods used by the Indonesian Council of Ulema (MUI) and Bahtsul Masail Nahdlatul Ulama concerning the fatwa on the AstraZeneca COVID-19 vaccine. The study method is qualitative, with a normative legal approach
Anisah Alkatiri, Idaul Hasanah, R. Tanzil Fawaiq Sayyaf   +2 more
doaj   +1 more source

NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II trials [PDF]

, 2008
<p><b>Background and Purpose:</b> In animal models of acute ischemic stroke (AIS), the free radical-trapping agent NXY-059 showed promise as a neuroprotectant.
Alderfer, V., Ashwood, T., Davalos, A., Davis, S.M., Diener, H.C., Grotta, J., Hardemark, H.G., Lees, K.R., Lyden, P., Rodichok, L., Shuaib, A., Wasiewski, W.   +11 more
core   +1 more source

Dermatological adverse effects of COVID-19 vaccines

Turkderm Turkish Archives of Dermatology and Venereology, 2022
Studies for vaccine development have been completed in an unprecedented time to prevent further outbreak of the dangerous and potentially fatal coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2 ...
Elçin Akdaş, Nilsel İlter
doaj   +1 more source

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial [PDF]

, 2017
Background: Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a BRCA mutation or high percentage of genome-wide loss of heterozygosity.
Aghajanian, C, Aghajanian, Carol, Amit, A, Armstrong, D K, Armstrong, Deborah K, Banerjee, S N, Birrer, M J, Bologna, A, Buck, M, Buss, M K, Cameron, Terri, Chambers, S K, Chen, L-m, Clamp, A, Clamp, Andrew, Coleman, R L, Coleman, Robert L, Colombo, N, Colombo, Nicoletta, Dean, A, Dean, Andrew, Denys, H, Dirix, L, Drew, Y, El-Balat, A, Elit, L, Floquet, A, Floquet, Anne, Fong, P C, Fong, Peter C, Friedlander, M L, Gabra, H G, Gancedo, M Amenedo, Gancedo, Margarita Amenedo, Garcia-Donas, J, Garcia-Donas, Jesus, Ghatage, P, Giordano, Heidi, Gladieff, L, Goble, Sandra, Goh, J C, Goh, Jeffrey C, Grace, Caroline, Guerra, E M, Harding, Thomas C, Harnett, P, Herraez, A Casado, Holloway, R W, Holloway, Robert W, Hänle, C, Isaacson, Jeff, Jackson, D, Joly, F, Kichenadasse, G, Konecny, G E, Konecny, Gottfried E, Kovel, S, Krabisch, P, Leary, A, Leary, Alexandra, Ledermann, J A, Ledermann, Jonathan A, Leviov, M, Lin, Kevin K, Lortholary, A, Lorusso, D, Lorusso, Domenica, Lotz, J, Ma, L, Maloney, Lara, McNeish, I A, McNeish, Iain A, Medioni, J, Morgan, M A, Morris, R T, Mutch, D G, Neunhöffer, T, O'Donnell, A, O'Malley, D M, O'Malley, David M, Oaknin, A, Oaknin, Ana, Oza, A M, Oza, Amit M, Palacio, I, Parkinson, C, Pignata, S, Plante, M, Powell, M, Provencher, D, Pölcher, M, Raponi, Mitch, Romero, I, Sabbatini, R F, Safra, T, Sanchez, A, Scambia, G, Scambia, Giovanni, Scott, C L, Scott, Clare L, Shapira-Frommer, R, Slomovitz, B M, Stemmer, S, Sun, James, Swisher, E M, Swisher, Elizabeth M, Tamberi, S, Tredan, O, Vanderkwaak, T, Vergote, I, Vulfovich, M, Weberpals, J I, Weberpals, Johanne I, Welch, S, Wimberger, P, You, B, Zamagni, C   +116 more
core   +1 more source

Acquired Thrombotic Thrombocytopenic Purpura after AstraZeneca Vaccine: a Case Report

Caspian Journal of Internal Medicine, 2022
Background: Rare cases of acquired thrombotic thrombocytopenic purpura (aTTP) have been reported since the administration of the COVID-19 vaccination. Based on our information, the present study provides the first case report of aTTP developed after the ...
Fatemeh Yaghoobi, Davood Dalil
doaj